Three of Orange County’s top CEO’s – Robert E. Grant (Bausch + Lomb), James V. Mazzo (Abbott Medical Optics) and Michael A. Mussallem (Edwards Lifesciences Corp.) – are joining nationally recognized healthcare policy expert Dr. Paul Keckley at the upcoming Forum for Corporate Directors (FCD) program to discuss the impact of the economy, healthcare reform and the upcoming election on their companies and boards. This “Dinner with the CEOs” will take place at the Hyatt Regency Irvine on Tuesday, November 29.
“Today’s challenging global and domestic economy, the impact of the pending healthcare reform on all types and sizes of companies and the implications of the 2012 election cycle provide plenty of uncertainty and potential challenges for today’s corporate directors, executive officers and senior level management,” said John Della Grotta, chair of FCD and a partner at Paul Hastings LLP. “This program will provide a unique opportunity to discuss these important issues facing all companies, with three of the most successful CEOs in Orange County.”
Grant is executive vice president and CEO Surgical, Bausch + Lomb. He joined the company in August, 2010, after serving as corporate vice president and president of Allergan Medical. He led the $3.4 billion Allergan-Inamed post-acquisition integration, and his leadership created the multi-million dollar medical rejuvenation industry through a portfolio of well-known products. Before joining Allergan Medical, Grant was the acting chairman, president and CEO of BIOLASE Technology, Inc., the global cosmetic dentistry company where he led a highly successful turnaround. He holds an MBA from the Thunderbird School of Global Management and has a bachelor’s degree from Brigham Young University.
Mazzo is senior vice president, Abbott Medical Optics, heading up the company’s global vision care business. He was appointed to his current role in February, 2009 after serving as chairman and CEO of Advanced Medical Optics. In that role, Mazzo grew the company’s sales from $538 million in 2002 to more than $1 billion in 2008 and increased the market cap from approximately $429 million to approximately $1.5 billion. During that time, he also engineered several strategic acquisitions worth more than $3 billion, staking the company to clear leadership positions in the cataract and eye care markets and the global No. 1 position in refractive surgery. He also held various senior executive-level positions for Allergan prior to its spin-off of Advanced Medical Optics, including president of Allergan’s Europe/Africa/Middle East region. He serves on the University of California at Irvine (UCI) Dean’s Board of Directors’ Executive Committee, UCI Dean’s Board of Business and Engineering and is chairman of the UCI Foundation. He is also a trustee for Chapman University and the University of San Diego. Additionally, Mazzo is a member of the International Intraocular Implant Club (IIIC) and serves as board chairman of AdvaMed.
Mussallem has been chairman and CEO of Edwards Lifesciences Corp. since 2000 when the company spun-off from Baxter International. Prior to his current position, he held a variety of positions with increasing responsibility in engineering, product development and senior management at Baxter, including group vice president of its cardiovascular business from 1994 to 2000 and group vice president of the biopharmaceutical business from 1998 to 2000. From 1996 until 1998, he was the chairman of Baxter’s Asia board overseeing Baxter’s operations throughout Asia. Mussallem is the former chairman of the board of directors of the Advanced Medical Technology Association (AdvaMed). He is currently on the boards and executive committees of AdvaMed, California Healthcare Institute and OCTANe, and is a trustee of the University of California, Irvine Foundation. He received a bachelor’s degree in chemical engineering and an honorary doctorate degree from the Rose-Hulman Institute of Technology in Terre Haute, Indiana.
Keckley is executive director for the Deloitte Center for Health Solutions (DCHS), the health care research arm of Deloitte, LLP. He brings a distinguished 30-year career in health sciences research in the private sector and academic medicine. A health economist and policy expert, he is a regular contributor to CNN and Fox News health reform coverage, and is considered one of the country’s leading experts on U.S. health reform. Prior to joining Deloitte, Keckley served in leadership roles at Vanderbilt Medical Center including international joint ventures, the Vanderbilt Center for Integrative Health, the health care MBA program launch and as executive director of the Vanderbilt Center for Evidence-based Medicine (VCEBM). He has published several articles in peer reviewed journals and continues to serve in the Vanderbilt University School of Medicine as a Visiting Professor and the Owen Graduate School of Business at Vanderbilt as an Adjunct Professor. He has authored three books and more than 200 articles, and publishes the Monday Health Reform Memo.
For more information about the FCD CEO Forum, or to register, please visit the Forum for Corporate Directors website at fdoc.org/.
About the Forum for Corporate Directors
Founded in 1991, the Forum for Corporate Directors (FCD) is a non-profit business organization committed to promoting the highest standards of corporate governance and to increasing the effectiveness of directors, CEOs and senior level executives by anticipating important issues facing companies in today’s global economy and presenting peer-to-peer forums to share ideas and key strategies. FCD members include many of Southern California’s top business and corporate leaders. Corporate members include Abbott Medical Optics; American Vanguard Corporation; California State University Fullerton Mihaylo College of Business & Economics; DDi Corp.; Emulex Corporation; Local.com; Microsemi Corporation; Mindspeed Technologies, Inc.; National Technical Systems; Newport Corporation; QLogic Corporation; Quality Systems Inc.; SRS Labs, Inc.; and The Paul Merage School of Business at UC Irvine.
The mission of FCD is generously supported by its Sponsors: Leadership Sponsors: RiechesBaird and Stradling, Yocca, Carlson and Rauth*; Legacy Sponsors: Grant Thornton LLP, KPMG LLP, Microsemi Corporation, and PricewaterhouseCoopers LLP; Heritage Sponsors: Deloitte, Ernst & Young LLP*, Latham & Watkins, The Lockton Companies Risk and Insurance, Paul Hastings LLP and Union Bank; Sustaining Sponsors: Abbott Medical Optics, Inc., Haskell & White LLP, The Paul Merage School of Business at UC Irvine, and McGladrey, Inc.; Supporting Sponsors: Allergan, Inc., BDO USA, LLP, Dorsey & Whitney LLP, Duff & Phelps, LLC, Emulex Corporation, Gibson, Dunn & Crutcher, LLP, Houlihan Lokey, [.], The Orange County Register, and Woodruff-Sawyer & Co.